Skip to main content
Isofol Medical logo

Isofol Medical — Investor Relations & Filings

Ticker · ISOFOL ISIN · SE0009581051 LEI · 549300MCXYAHG7VBHX75 ST Professional, scientific and technical activities
Open in API
Filings indexed 208 across all filing types
Latest filing 2022-11-03 AGM Information
Country SE Sweden
Listing ST ISOFOL

About Isofol Medical

https://isofolmedical.com/

Isofol Medical is a clinical-stage biotechnology company dedicated to improving treatments for severe forms of cancer. The company's primary focus is the development of its lead drug candidate, arfolitixorin. This next-generation, folate-based therapy is designed to enhance the efficacy of standard cancer treatments, such as chemotherapy. Arfolitixorin is the active metabolite of commonly used folate-based drugs, potentially offering a therapeutic benefit to a broader patient population by bypassing complex metabolic activation steps. The company's goal is to help more patients respond better to their treatment, thereby improving their prognosis.

Recent filings

Filing Released Lang Actions
Isofol har utsett valberedningen inför årsstämman 2023
AGM Information Classification · 95% confidence The document is a press release from Isofol Medical AB, dated November 3, 2022, announcing the appointment of the members of the Nomination Committee (Valberedningen) ahead of the 2023 Annual General Meeting (Årsstämman). This announcement concerns the composition of a committee responsible for nominating board members and setting the agenda for the AGM, which is a governance-related activity. It is not the AGM presentation itself (AGM-R), nor is it a formal proxy statement (DEF 14A/PSI). Since it deals specifically with the composition and process related to the nomination of directors for the upcoming AGM, it falls under general corporate governance information, but the specific focus on the nomination committee composition and shareholder representation aligns closely with the scope of Board/Management Information (MANG) or Governance Information (CGR). Given that the nomination committee's primary role is tied to board composition and shareholder rights regarding board elections, and it is a specific announcement about a governance body's setup, MANG (Board/Management Information) is a strong candidate, as is CGR (Governance Information). However, the content is highly specific to the *process* leading up to the AGM regarding board nominations, which is a core governance function. Since there isn't a perfect fit for 'Nomination Committee Announcement', I will classify it as Governance Information (CGR) as it details internal rules/structure related to board appointments, or potentially MANG. Given the context of shareholder involvement in appointing the committee, CGR seems slightly more appropriate than MANG, which usually covers changes in existing management/board personnel. Alternatively, as a specific announcement about a pre-AGM governance body, it could also be considered a Regulatory Filing (RNS) if CGR/MANG were deemed too broad, but CGR is a better fit for governance structure details. I will select CGR as the most specific fit for detailing the structure and appointment process of the body responsible for board nominations.
2022-11-03 Swedish
Isofol appoints nomination committee ahead of the Annual General Meeting 2023
AGM Information Classification · 98% confidence The document explicitly announces the appointment of members to the nomination committee ahead of the 'Annual General Meeting 2023'. This content directly relates to the preparatory steps and governance structure surrounding the AGM. While it mentions the AGM, it is not the meeting presentation itself (AGM-R), nor is it a proxy statement (DEF 14A/PSI). It is a specific announcement regarding the governance body responsible for nominating directors and setting proposals for the AGM. This falls best under Governance Information (CGR) as it details the structure and appointment of a key governance body, or potentially a specific type of Board/Management Information (MANG) related to governance appointments. Given the focus on the 'nomination committee' and its composition, CGR (Governance Information) is the most precise fit, as it deals with internal rules and board structure preparation. However, since the context is explicitly tied to the upcoming AGM, and the document details the composition of the committee that will propose candidates for the AGM, it is a governance announcement related to the meeting structure. Reviewing the definitions, CGR covers 'internal rules, board structure, and governance practices.' This announcement details the composition of a key governance body (the nomination committee) for the upcoming AGM. It is not a general management change (MANG) or a proxy solicitation (PSI). Therefore, CGR is the most appropriate classification.
2022-11-03 English
Major Shareholding Notification 2022
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding, specifically reporting the 'Resulting distribution of total holdings' and noting a 'Reason for major shareholding notification' related to crossing a 5% limit. The structure, use of terms like 'Holder', 'Shares', 'Voting rights', and the explicit mention of 'major shareholding notification' strongly indicate a filing related to significant ownership changes. This aligns directly with the definition for Major Shareholding Notification (MRQ). The document is short and appears to be the notification itself, not an announcement of a report.
2022-10-20 English
Major Shareholding Notification 2022
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding percentage by a holder (Avanza Bank Holding AB for Avanza Pension) in Isofol Medical AB. It explicitly mentions 'Reason for major shareholding notification' and provides the 'Resulting distribution of total holdings' and 'Group total holdings' with specific percentages and share quantities. This structure perfectly matches the definition of a Major Shareholding Notification, which corresponds to the filing code MRQ.
2022-10-13 English
Major Shareholding Notification 2022
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding and voting rights for a specific holder (Avanza Bank Holding AB for Försäkringsaktiebolaget Avanza Pension) involving a specific quantity of shares and resulting percentages. This structure, focusing on insider/major shareholder transactions and resulting ownership percentages, strongly aligns with the definition of a Major Shareholding Notification. The date of the transaction (07/09/2022) and publication date (08/09/2022) confirm it is a timely report of a change in ownership crossing a threshold. This matches the 'Major Shareholding Notification' category (MRQ).
2022-09-08 English
Isofol redovisar data från AGENT-studien
Earnings Release Classification · 95% confidence The document is a press release dated September 7, 2022, announcing study data from the AGENT trial, detailing statistical results (P-values, PFS, ORR) and the decision to stop the trial due to limited commercial value. It discusses clinical results and the subsequent plan to wind down the study ethically and regulatorily, while the board explores shareholder value options. This content is characteristic of an Earnings Release (ER) or a detailed announcement accompanying financial/study results, rather than the full comprehensive report (like 10-K or IR). Since it focuses on the immediate release of key performance data and the resulting business decision, 'ER' (Earnings Release) is the most appropriate classification, as it is a primary announcement of period-specific performance outcomes, even if the period is a clinical trial phase rather than a fiscal quarter. It is not a transcript (CT), a formal annual report (10-K), or just a notice of a report being published (RPA). FY 2022
2022-09-07 Swedish

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.